✦ LIBER ✦

A Pharmacokinetic Study Evaluating the Relationship Between Treatment Efficacy and Incidence of Adverse Events with Thalidomide Plasma Concentrations in Patients with Refractory Multiple Myeloma

✍ Scribed by Kodama, Tomoko; Abe, Masahiro; Iida, Shinsuke; Ozaki, Shuji; Sakai, Akira; Sawamura, Morio; Shimazaki, Chihiro; Miyata, Akira; Wakayama, Toshio; Murakami, Hirokazu

Book ID: 119936103
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 123 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.n.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of a bortezomib, cyclo

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

✍ Yeo-Kyeoung Kim; Sang-Kyun Sohn; Jae-Hoon Lee; Deok-Hwan Yang; Joon-Ho Moon; Jae 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

Consensus guidelines for the optimal man

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma

✍ A. Palumbo; F. Davies; M. Kropff; J. Bladé; M. Delforge; F. Leal da Costa; R. Ga 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

(761): A randomized, double-blind, place

(761): A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects

✍ L. Webster; J. Jansen; J. Peppin; B. Lasko; J. Snidow; A. Pierce; E. Mortensen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB